Velarion Records
Free. Unsubscribe any time.

Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics, Inc. filed 31 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 64 transactions and 416,718 shares. None carries the SEC's AFF10B5ONE flag; all 31 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Stoke Therapeutics, Inc. 64

Adoption dates in Stoke Therapeutics, Inc. 7

Results prints in Stoke Therapeutics, Inc. 7

Trades before a print in Stoke Therapeutics, Inc. 6

Interval to Stoke Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Stoke Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on November 12, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.